Biotech · Private company
Matrix Biomed, Inc.
Track this companyFree. Adds Matrix Biomed, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- MBM-01Phase 2 · Ataxia Telangiectasia Louis-BarClinicalTrials.gov · fetched Nov 12, 2026
- MBM-02Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- MBM-02Phase 2 · Prostate Cancer RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- TempolPhase 2 · MucositisClinicalTrials.gov · fetched Nov 12, 2026
- MBM-02 (Tempol)Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- TempolMetastatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- MBM-01 (Tempol) for the Treatment of Ataxia TelangiectasiaPHASE2 · UNKNOWN · started Jul 1, 2021ClinicalTrials.gov NCT04887311 · fetched Nov 12, 2026
- MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)PHASE2 · UNKNOWN · started Jun 1, 2021ClinicalTrials.gov NCT04874506 · fetched Nov 12, 2026
- MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate CancerPHASE2 · UNKNOWN · started May 30, 2021ClinicalTrials.gov NCT04876755 · fetched Nov 12, 2026
- Treatment of Radiation and Cisplatin Induced Toxicities with TempolPHASE2 · RECRUITING · started May 13, 2019ClinicalTrials.gov NCT03480971 · fetched Nov 12, 2026
- Treatment of Metastatic Cancer in Terminally Diagnosed PatientsAVAILABLEClinicalTrials.gov NCT05491928 · fetched Nov 12, 2026
- A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate CancerAVAILABLEClinicalTrials.gov NCT04337099 · fetched Nov 12, 2026